Karolinska Development invests in medical innovations that can be developed into ground-breaking treatments for severe diseases.
Karolinska Development invests in life science companies that develop potentially ground-breaking treatments to alleviate or cure severe diseases.
The goal is to make a difference to patients’ lives and generate high returns for shareholders.
Read more about Karolinska Development here